2023 Agenda

EXPERIENCE

Partnership Pursuit: Physician & Entrepreneur Reception (invite only)

This is a unique opportunity for you to meet these innovative entrepreneurs and determine if there is a mutually beneficial fit and interest. These companies will be within the medical industry, not necessarily ophthalmic specific, and provide a good opportunity to contribute your diverse perspective. Octane is uniquely qualified to provide this opportunity as we bridge the relationships we have with physicians and the companies that have used our LaunchPad accelerator. We look forward to welcoming you to Balboa Bay Resort in Newport Beach.

EXPERIENCE

Welcome Reception (invite only) 

EXPERIENCE

Registration, Exhibits & Continental Breakfast

Network with colleagues! You can also set appointments within our virtual platform or take part in a networking session catered to your interests.

OPENING

Opening Comments

Octane CEO, Bill Carpou will reflect on the impact of ophthalmology in Southern California and beyond.

Bill Carpou, CEO, Octane

Emcee

Yari Mitchell, President, Y Factor Consulting Inc.

State of the Ophthalmic Industry Report

This panel will discuss the state of the current eyecare industry. The panel will focus on how the eyecare index is performing, current investment trends, and opportunities.

Kristen Ingenito, MBA, Vice President, Market Scope, LLC (Moderator)

Megan Driscoll, CEO & Founder, EvolveMKD

Sheri Rowen, MD, FACS, NVision Eye Centers

Jeffry Weinhuff, Founder & Managing Partner, Visionary Venture Fund

KEYNOTE

Keynote Interview

Bill Carpou, CEO, Octane

Mark Leahey, President & CEO, MDMA

PANEL

Turning the Tide

This panel will feature industry leaders and companies that have experienced great challenges and adversity yet were able to successfully turn the tide. This session will provide lessons and pearls gathered from their experiences.

John Hovanesian, MD, FACS, Private Practice, Harvard Eye Associates, Laguna Hills, CA Clinical Faculty, UCLA Jules Stein Eye Institute, Los Angeles, CA (Moderator)

Chris Calcaterra, Executive Vice President, Global Commercial Operations, Glaukos Corporation

Tara Capalbo, General Manager, Glaucoma, Allergan, an AbbVie Company

Daniel Durrie, MD, Chairman, iOR Partners, Founder, Durrie Vision (RxSight)

Magda Michna, PhD, Chief Clinical, Regulatory, and Medical Affairs Officer, STAAR Surgical

Adam Szaronos, President & CEO, Trukera Medical

PANEL

What Keeps You Up At Night?

This panel will share their opinions and experiences on what keeps them up at night. The discussion will focus on the current and future state of eye care and Include perspectives from legal, regulatory, and clinical.

Kuldev Singh, MD, MPH, Professor of Ophthalmology and Director of the Glaucoma Service, Stanford University (Moderator)

Robert J. Dempsey, President & CEO, AsclepiX Therapeutics, Inc

Mark Kontos, MD, Empire Eye Physicians

Timothy Pratt, PhD, Executive Director, and Global Head Medical Device & Diagnostics Research, ICON

EXPERIENCE

Break: Networking, Exhibits & Coffee

PANEL

Innovations in the Posterior Segment

For the second year at OTF, we welcome hearing about innovations, trends, and opportunities in the posterior segment.

Robert L. Avery, MD, California Retina Consultants (Co-Moderator)

Baruch Kuppermann, MD, PhD, Steinert Endowed Professor, Chair, Department of Ophthalmology, Director, Gavin Herbert Eye Institute, University of California, Irvine (Co-Moderator)

Caroline Baumal, MD, Chief Medical Officer, Apellis Pharmaceuticals, Inc.

David Esposito, CEO, ONL Therapeutics

Richard Small, CEO, Neurotech

Ramin Valian, Vice President- US Eye Care, Allergan, an AbbVie Company

PANEL

Disruptive Innovations

This panel will focus on current and future disruptive innovations in eyecare including presbyopia, pharma, cataract, AI, and more.

Ehsan Sadri, MD, FACS, CEO & Founder, Visionary Eye Institute (Moderator)

Warren Foust, Chief Operating Officer, STAAR Surgical

Greg Kunst, CEO, Aurion Biotech

Aziz Mottiwala, Chief Commercial Officer, Tarsus Pharmaceuticals, Inc.

Marc Odrich, MD, Chief Medical Officer, LENZ Therapeutics

Paul Smith, President & COO, Orasis Pharmaceuticals

Luis G. Vargas, MD, Head Clinical Science, Johnson & Johnson Vision

PANEL

The Great Debate- Is the office-based surgical movement good for ophthalmology?

This session will debate the ophthalmology hot topic of In-Office Surgery. Hear from surgeons and industry representatives on both sides of the issue.

Daniel Durrie, MD, Chairman, iOR Partners, Founder, Durrie Vision (Moderator)

Cindy Metrose, Senior Director, Strategic Accounts and Digital Business, Zeiss

Leslie Patch, MD, Medical Director, Johnson & Johnson Vision

Ehsan Sadri, MD, FACS, CEO & Founder, Visionary Eye Institute

Omar Shakir, MD, MBA, Coastal Eye Surgeons

James Williams, President & CEO, iOR Partners

FIRESIDE CHAT

Jim Mazzo, Executive Chairman, Neurotech, Co-Founder, Octane

Brent Saunders, Chairman and CEO, Bausch & Lomb

EXPERIENCE

Break: Exhibits & Set for Lunch

EXPERIENCE

The Roger Steinert, MD Legacy Award Presented by The Gavin Herbert Eye Institute

LUNCH & EXPERIENCE

Capital & Growth Presentations

Andrew Douglas, Partner, Knobbe Martens (Moderator)

Michael Hill, Managing Director, Octane Capital Markets

Presenting Companies:

• Viewpoint Therapeutics
• OkuloVision
• Implandata Ophthalmic Products
• i-Lumen Scientific
• Pixium Vision

Judges

Sanjeev Ganatra, Chief Commercial Officer, IUVO Biosciences 

David LeCause, General Manager, Anterior Segment; Allergan, and AbbVie Company

Jai G Parekh, MD, MBA, EVP/Chief Innovation Officer, EyeCheq & Founder, EyeCare Consultants of NJ

EXPERIENCE

Break: Exhibits & Networking

PANEL

The Investment Landscape

Jeffry Weinhuff, Founder & Managing Partner, Visionary Venture Fund (Moderator)

Andrew Gitkin, Vice Chairman, Healthcare Investment Banking, Raymond James

Jeffrey Nau, PhD, President, Viatris Eye Care Division

Andrew Stewart, President, Ophthalmic Pharmaceuticals,Bausch + Lomb Corporation

Marty Waters, Partner, Wilson Sonsini

FIRESIDE CHAT

Alcon & Aerie Acquisition

Laurent Attias, Executive Committee, SVP, Corporate Development Strategy, BD&L and M&A, Alcon

Tom Mitro, Previous President, Aerie Pharmaceuticals

PANEL

Bringing Unmet Needs to Market

This panel will focus on the opportunities for collaborative care in eye care. This panel will feature ODs, MDs, and industry representatives that will discuss the opportunities in collaborative healthcare.

Richard Lindstrom, MD, Minnesota Eye Consultants (Moderator)

Lloyd Diamond, CEO, PIXIUM VISION

Michael Garanzini, Senior Director, Marketing, Sun Ophthalmics

Yehia Hashad, MD, Executive Vice President, R&D and Chief Medical Officer, Bausch + Lomb

Selina McGee, OD, FAAO, BeSpoke Vision

Richard Minevich, Director, Global Marketing Strategy & Operations, Johnson & Johnson Vision

PANEL

The Changing Landscape of Eyecare: Challenges and Digital Solutions for the Next Generation of Eye Surgeons

This panel will focus on the future of eyecare and what the next generation of young surgeons and Industry representatives are facing. The discussion will focus on products and innovations.

Aimee Shimamoto, Director of Marketing, Americas, BVI (moderator)

Luis Diaz Santana, Vice President Ophthalmology, Cambridge Consultants

Omar Shakir, MD, MBA, Coastal Eye Surgeons

Dagny Zhu, MD, Medical Director and Partner, NVISION Eye Centers 

PANEL

Innovations of the Future

Up and coming startups and products. 5-minute pitches about where they are in the commercialization process.

Kevin Cady, President & CEO, OnPoint Vision Inc.

Daniel Durrie, MD, Chairman iOR Partners, Founder, Durrie Vision (RxSight), (representing 2EyesVision)

Norbert Lowe, Vice President, Head of Commercial, Eyenovia

John Pollack, MD, Chief Medical Officer, jCyte, Inc. 

Stephen Smith, MD, Founder & CEO, iRenix Medical, Inc.

Closing Comments

Bill Carpou, CEO, Octane

Closing Reception

EXPERIENCE

Advisory Board Opportunities